Hedge Fund - Farallon Capital
Revolution Medicines Inc. (RVMD)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $1,161,519,701 | 5.48% | 14,582,796 | $65.57 |
| 2 | 2025 - Q3 (2025-09-30) | $683,019,816 | 2.8% | 14,625,692 | $39.15 |
| 3 | 2025 - Q2 (2025-06-30) | $527,042,209 | 2.21% | 14,325,692 | $38.42 |
| 4 | 2025 - Q1 (2025-03-31) | $478,586,709 | 2.29% | 13,534,692 | $40.59 |
| 5 | 2024 - Q4 (2024-12-31) | $579,497,788 | 2.54% | 13,248,692 | $50.47 |
| 6 | 2024 - Q3 (2024-09-30) | $513,257,332 | 2.25% | 11,317,692 | $43.54 |
| 7 | 2024 - Q2 (2024-06-30) | $378,696,027 | 1.62% | 9,757,692 | $37.38 |
| 8 | 2024 - Q1 (2024-03-31) | $241,978,715 | 1.02% | 7,507,872 | $29.64 |
| 9 | 2023 - Q4 (2023-12-31) | $193,212,973 | 0.88% | 6,736,854 | $24.03 |
| 10 | 2023 - Q3 (2023-09-30) | $92,049,286 | 0.42% | 3,325,480 | $29.66 |
| 11 | 2023 - Q2 (2023-06-30) | $74,458,090 | 0.37% | 2,783,480 | $24.54 |
| 12 | 2023 - Q1 (2023-03-31) | $71,122,776 | 0.38% | 3,283,600 | $24.62 |
| 13 | 2022 - Q4 (2022-12-31) | $40,446,717 | 0.23% | 1,698,015 | $21.26 |
| 14 | 2022 - Q3 (2022-09-30) | $49,300,000 | 0% | 2,500,000 | $21.98 |
| 15 | 2022 - Q2 (2022-06-30) | $63,343,000 | 0% | 3,250,000 | $19.47 |
| 16 | 2022 - Q1 (2022-03-31) | $82,908,000 | 0.01% | 3,250,000 | $21.77 |
| 17 | 2021 - Q4 (2021-12-31) | $69,218,000 | 0.02% | 2,750,000 | $28.18 |
| 18 | 2021 - Q3 (2021-09-30) | $75,653,000 | 0.03% | 2,750,000 | $29.11 |
| 19 | 2021 - Q2 (2021-06-30) | $79,350,000 | 0.04% | 2,500,000 | $34.90 |
| 20 | 2021 - Q1 (2021-03-31) | $73,854,000 | 0.36% | 1,609,730 | $44.84 |
| 21 | 2020 - Q2 (2020-06-30) | $0 | 0% | 0 | $31.44 |
| 22 | 2020 - Q1 (2020-03-31) | $454,000 | 0% | 20,733 | $27.68 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center